Loading…
www.buycodeine.us was cited for unlawfully selling unapproved and misbranded opioid and Schedule II stimulant drugs over the internet in violation of the Federal Food, Drug, and Cosmetic Act (sections 301(a), 301(d), 301(k), 503(b), and 505(a)). The company's website introduced these drug products into interstate commerce without FDA approval or proper labeling, circumventing regulatory oversight and the safety and efficacy assurances required for approved medications. The FDA emphasized that easy internet availability of these controlled substances poses significant public health risks, particularly given the ongoing opioid epidemic and the high abuse potential of Schedule II stimulants, which are frequently diverted for nonmedical use among young adults and college students.